(Q41101339)

26 September 2017

1 reference

title

Current concepts of sepsis and acute lung injury (English)

1 reference

26 September 2017

0 references

Sessler CN

1

1 reference

26 September 2017

Bloomfield GL

series ordinal

2

1 reference

26 September 2017

Fowler AA 3rd

series ordinal

3

1 reference

26 September 2017

publication date

1 June 1996

1 reference

Clinics in Chest Medicine

26 September 2017

published in

1 reference

26 September 2017

volume

17

1 reference

26 September 2017

issue

2

1 reference

26 September 2017

page(s)

213-235

1 reference

E-selectin supports neutrophil rolling in vitro under conditions of flow

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Adhesion molecules and inflammatory injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Relative contribution of the leukocyte molecules Mo1, LFA-1, and p150,95 (LeuM5) in adhesion of granulocytes and monocytes to vascular endothelium is tissue- and stimulus-specific

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Acute respiratory distress in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Multiple organ system failure and infection in adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Inhaled nitric oxide lowers pulmonary capillary pressure and changes longitudinal distribution of pulmonary vascular resistance in patients with acute lung injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

High-dose corticosteroids in patients with the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

1 reference

7 January 2021

Identification of an inducible endothelial-leukocyte adhesion molecule

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

HA-1A in septic patients with ARDS: results from the pivotal trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Prolonged inhalation of low concentrations of nitric oxide in patients with severe adult respiratory distress syndrome. Effects on pulmonary hemodynamics and oxygenation.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Adult respiratory distress syndrome. Sequence and importance of development of multiple organ failure. The Prostaglandin E1 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Randomized double-blind, multicenter study of prostaglandin E1 in patients with the adult respiratory distress syndrome. Prostaglandin E1 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Characterization of a human homologue of the murine peripheral lymph node homing receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Identification of a soluble form of a ligand for the lymphocyte homing receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Increased morbidity with increased pulmonary albumin flux in sepsis-related adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Membrane proteins involved in phagocyte adherence to endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

The systemic inflammatory response syndrome (SIRS): immunology and potential immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18)

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

A prospective study of lung water measurements during patient management in an intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

The risk factors, incidence, and prognosis of ARDS following septicemia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Effect of inhaled nitric oxide on right ventricular function in adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Adult respiratory distress syndrome: risk with common predispositions

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

The three members of the selectin receptor family recognize a common carbohydrate epitope, the sialyl Lewis(x) oligosaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Effects of positive end-expiratory pressure on regional distribution of tidal volume and recruitment in adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

CT scan in ARDS: clinical and physiopathological insights

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Selectin GMP-140 (CD62; PADGEM) binds to sialosyl-Lea and sialosyl-Lex, and sulfated glycans modulate this binding

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

A simple multiple system organ failure scoring system predicts mortality of patients who have sepsis syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Manipulating hemodynamics and oxygen transport in critically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Prostaglandin E1 and survival in patients with the adult respiratory distress syndrome. A prospective trial

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Clinical risks for development of the acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Improved survival in ARDS patients associated with a reduction in pulmonary capillary wedge pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Antioxidant treatment with N-acetylcysteine during adult respiratory distress syndrome: a prospective, randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Evaluation of definitions for adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

The acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

The prone position in ARDS patients. A clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Surfactant and the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Pulmonary fibrosis correlates with outcome in adult respiratory distress syndrome. A study in mechanically ventilated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

The CD14 differentiation antigen mediates the development of endotoxin responsiveness during differentiation of mononuclear phagocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983-1993

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Improved outcome based on fluid management in critically ill patients requiring pulmonary artery catheterization.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Establishing the relative accuracy of three new definitions of the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Protective effects of sialylated oligosaccharides in immune complex-induced acute lung injury

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

An expanded definition of the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Interleukin-1 receptor antagonist reduces mortality from endotoxin shock

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Computed tomography in established adult respiratory distress syndrome. Correlation with lung injury score

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

The effect of kinetic positioning on lung function and pulmonary haemodynamics in posttraumatic ARDS: a clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Influence of positioning on ventilation-perfusion relationships in severe adult respiratory distress syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Septic shock. Hemodynamics and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Vertical gradient of regional lung inflation in adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Clinical predictors of the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

The adult respiratory distress syndrome. Clinical features, factors influencing prognosis and principles of management.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

The neutrophil selectin LECAM-1 presents carbohydrate ligands to the vascular selectins ELAM-1 and GMP-140.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Prostaglandin E1 and nitroglycerin reduce pulmonary capillary pressure but worsen ventilation-perfusion distributions in patients with adult respiratory distress syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Prostacyclin for the treatment of pulmonary hypertension in the adult respiratory distress syndrome: effects on pulmonary capillary pressure and ventilation-perfusion distributions

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Randomized, prospective trial of pressure-limited versus volume-controlled ventilation in severe respiratory failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

No differences in hemodynamics, ventricular function, and oxygen delivery in septic and nonseptic patients with the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Inhaled nitric oxide for the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Efficacy of inhaled nitric oxide in patients with severe ARDS

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Effects of inhaled nitric oxide on right ventricular function in severe acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Endothelial cell binding of NAP-1/IL-8: role in neutrophil emigration

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Oxygen delivery and consumption and ventricular preload are greater in survivors than in nonsurvivors of the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Distribution of regional density and vascular permeability in the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Soluble L-selectin is present in human plasma at high levels and retains functional activity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Frequency and importance of barotrauma in 100 patients with acute lung injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Fluid balance during pulmonary edema. Is fluid gain a marker or a cause of poor outcome?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Structure and function of lipopolysaccharide binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

What is acute lung injury? What is ARDS?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Should inverse ratio ventilation be used in adult respiratory distress syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Human homologue of mouse lymph node homing receptor: evolutionary conservation at tandem cell interaction domains

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Pulmonary endothelial permeability in patients with severe lung injury. Clinical correlates and natural history

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

A multicenter registry of patients with acute respiratory distress syndrome. Physiology and outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Right ventricular function and oxygen transport patterns in patients with acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Role of tumor necrosis factor-alpha in disease states and inflammation.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

N-acetylcysteine enhances recovery from acute lung injury in man. A randomized, double-blind, placebo-controlled clinical study.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Characterization of exosurf (surfactant)-mediated suppression of stimulated human alveolar macrophage cytokine responses

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Elevation of cardiac output and oxygen delivery improves outcome in septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Permissive hypercapnic ventilation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

The incidence of the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Monoclonal antibody to tumor necrosis factor alpha attenuates cardiopulmonary dysfunction in porcine gram-negative sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Recognition by Elam-1 of the Sialyl-Le x Determinant on Myeloid and Tumor Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Safety and potential efficacy of an aerosolized surfactant in human sepsis-induced adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Delayed tumor necrosis factor alpha blockade attenuates pulmonary dysfunction and metabolic acidosis associated with experimental gram-negative sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Tumor necrosis factor-alpha blockade prevents neutrophil CD18 receptor upregulation and attenuates acute lung injury in porcine sepsis without inhibition of neutrophil oxygen radical generation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

A double-blind, prospective, randomized trial of ketoconazole, a thromboxane synthetase inhibitor, in the prophylaxis of the adult respiratory distress syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Frequency of mortality and myocardial infarction during maximizing oxygen delivery: a prospective, randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Nitric oxide and the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970310-5

7 January 2021

10.1016/S0272-5231(05)70310-5

Identifiers

DOI

1 reference

26 September 2017

1 reference